- Home
- BKU vs ZLAB Comparison
BKU vs ZLAB Comparison
Compare BKU & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKU | ZLAB |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.6B |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BKU | ZLAB |
|---|---|---|
| Price | $44.78 | $24.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $51.58 | $49.60 |
| AVG Volume (30 Days) | 549.9K | ★ 1.0M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | 14.61 | ★ 38.46 |
| EPS | ★ 1.79 | N/A |
| Revenue | $21,732,000.00 | ★ $460,156,000.00 |
| Revenue This Year | $16.26 | $9.75 |
| Revenue Next Year | $4.78 | $26.03 |
| P/E Ratio | $25.25 | ★ N/A |
| Revenue Growth | 7.45 | ★ 15.33 |
| 52 Week Low | $35.10 | $15.96 |
| 52 Week High | $52.11 | $34.72 |
Technical Indicators
Market Signals| Indicator | BKU | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 39.67 | 47.84 |
| Support Level | $44.34 | $16.84 |
| Resistance Level | $45.65 | $27.22 |
| Average True Range (ATR) | 0.92 | 0.81 |
| MACD | -0.08 | -0.40 |
| Stochastic Oscillator | 26.45 | 16.06 |
Price Performance
Historical ComparisonAbout BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.